Development and Evaluation of a Hormone Replacement Therapy Decision-Aid
NCT ID: NCT00012909
Last Updated: 2015-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2004-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Menopause Interactive Decision Aid System
NCT00345072
Measuring Quality of Decisions About Treatment of Menopausal Symptoms
NCT01152294
Reduction of Triglycerides in Women on Hormone Replacement Therapy
NCT00023543
Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women
NCT00005769
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function
NCT03112226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The decision regarding the use of post-menopausal estrogen hormone replacement therapy (HT) is complex because patients must balance the short and long-term risks and benefits. Information from new and important clinical trials must also be considered. The purpose of this research is to develop and evaluate the efficacy of a HT CD-ROM decision-aid in improving the decision making process for women considering the use of estrogen HT.
Objectives:
The objectives of the study are to: 1) develop a model of the decision-making process for postmenopausal women considering hormone (HT), based on Multi-Attribute Utility Theory (MAUT); 2) produce an interactive CD-ROM decision-aid for HT; 3) evaluate the effect of the interactive CD-ROM decision-aid on patient satisfaction with decision (SWD) and knowledge about menopause and HT; and 4) test the effect of the interactive CD-ROM decision-aid on women�s decisions regarding use of HT.
Methods:
Phase I (completed) used structured interviews and surveys in the development of a decision model for HT. In phase II, an interactive CD-ROM decision-aid was developed and a randomized controlled trial (RCT) of its effect on decision processes was conducted. Postmenopausal women, aged 45-74 were recruited from the primary care clinics of the four participating Veterans Affairs hospitals: Milwaukee, Madison, Chicago-Hines, and Chicago-Westside. The primary hypothesis was that women who use the CD-ROM decision-aid would demonstrate increased satisfaction with their decision regarding hormone replacement therapy use compared to women receiving the control intervention.
Status:
Enrollment and follow-up assessments have been completed. The study is in the analysis phase. The study was presented to the VA HSR\&D Combined Monitoring Board on February 5, 2003 and the committee voted unanimously to recommend continuation of the trial. The study has had one publication and several scientific abstract presentations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1
Hormone Replacement Therapy Decision-Aid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hormone Replacement Therapy Decision-Aid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* are assessed not to have capacity for making medical decisions for their own care
* had alcohol or drug abuse issues in past 6 months before baseline visit
* personal history of breast cancer, active liver disease, active vascular thrombosis, and/or active unexplained vaginal bleeding
45 Years
74 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marilyn M. Schapira, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Clement J. Zablocki VA Medical Center, Milwaukee, WI
Arneda Van White, MD
Role: PRINCIPAL_INVESTIGATOR
Edward Hines Jr. VA Hospital, Hines, IL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, United States
Clement J. Zablocki VA Medical Center, Milwaukee, WI
Milwaukee, Pennsylvania, United States
William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schapira MM, Gilligan MA, McAuliffe TL, Nattinger AB. Menopausal hormone therapy decisions: insights from a multi-attribute model. Patient Educ Couns. 2004 Jan;52(1):89-95. doi: 10.1016/s0738-3991(02)00266-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCC 98-039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.